medigraphic.com
ISSN 1560-4381 (Print)

2019, Number 1

<< Back Next >>

Correo Científico Médico 2019; 23 (1)

Hospitalization caused by adverse drug reactions

Rodríguez DR, Gómez LB, Rodríguez MY, Díaz AMT

Language: Spanish
References: 45
Page: 223-243
PDF size: 134.36 Kb.


ABSTRACT

Adverse Drug Reactions are frequent and preventable, a poorly studied cause of morbidity and mortality. Several factors may influence the occurrence of these undesirable effects. They may involve physiological or pathological factors, apart from the environmental and socio-cultural environment. Increasing data suggest that, adverse drug events are frequent in hospital environments and may cause substantial damage. They become a huge burden for hospitals due to prolonged hospitalizations and high admission rates, which affect hospital costs. Hospitalization rates prevalence for drug-related problems range from 5% to 12%, in the studies review. It is necessary to improve safe use of medicines and strategies for the usual clinical practice, to reduce the negative impact of Adverse Drug Reactions.


REFERENCES

  1. Eaton L. Adverse reactions to drugs increase. BMJ. 2002 [citado 2 mar 2018]; 324 (7328):8.Disponible en: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1121978

  2. Cruz Barrios AM, Furones Mourelle JA, Broche Villarreal L, Báez Allende L, Lopeztegui Jay I. Farmacovigilancia de medicamentos cubanos en revistas médicas nacionales. Rev Med Electrón. 2012[citado 12 mar 2018]; 34 (6). Disponible en: http://scielo.sld.cu/scielo.php? script=sci_arttext&pid=S1684-18242012000600002

  3. McKendrick J, Coats J, Newman D. Report on the Action of Anæsthetics to the Scientific Grants Committee of the British Medical Association. Br Med J. 1880 [citado 2 mar 2018]; 2(1042): 957–972. Disponible en: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2241527

  4. Aranaz Andrés JM. Estudio Nacional sobre los efectos adversos ligados a la Hospitalización. ENEAS 2005. Madrid: Ministerio de Sanidad y Consumo; 2006[citado 26 may 2017].Disponible en: https://www.mscbs.gob.es/organizacion/sns/planCalidadSNS/pdf/excelencia/opscsp2.pdf

  5. Gossell-Williams M, Adebayo SA. The PharmWatch programme: challenges to engaging the community pharmacists in Jamaica. Pharmacy Pract (Granada). 2008 [citado 24 sep 2017] ; 6(4):187-190. Disponible en: http://scielo.isciii.es/scielo.php?script=sci_arttext&pid=S1885- 642X2008000400003&lng=es

  6. Armentia Medina A, Martín Armentia S. Alergia a medicamentos y drogas. Pediatr Integral. 2018[citado 24 sep 2018];22(3):147-154. Disponible en: https://www.pediatriaintegral.es/wpcontent/ uploads/2018/05/Pediatria-Integral-XXII-3_WEB.pdf#page=44

  7. Fricke-Galindo I, Jung-Cook H, LLerena A, López-López M. Farmacogenética de reacciones adversas a fármacos antiepilépticos. Neurología. 2018[citado 20 sep 2018];33(3):165-176. Disponible en: https://www.clinicalkey.es/#!/content/playContent/1-s2.0- S0213485315000560?returnurl=https:%2F%2Flinkinghub.elsevier.com%2Fretrieve%2Fpii %2FS0213485315000560%3Fshowall%3Dtrue&referrer=

  8. Holloway K, Green T. Comité de Farmacoterapia- Guía Práctica. Suiza :OMS;2003[29 oct 2018;30 oct 2018]. Disponible en : http://apps.who.int/medicinedocs/es/d/Js8121s/7.4.html#Js8121s.7.4

  9. Wu TH, Karim N, Moscow JA. Distinguishing mechanisms of adverse drug reactions from mechanisms of actions of drugs. Oncotarget. 2018 [citado 2 mar 2018];9(65):32404-32405. Disponible en: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6126701

  10. Naranjo CA, Shear NH, Lanctot KL. Advances in the diagnosis of adverse drug reactions. J Clin Pharmacol. 1992[citado 2 mar 2017]; 32 (10): 897-904. Disponible en: http://onlinelibrary.wiley.com/doi/10.1002/j.1552-4604.1992.tb04635.x/full

  11. Strauss J, Greeff OBW. Excipient-related adverse drug reactions: a clinical approach. Curr Allergy Clin Immunol J. 2015[citado 2 mar 2017]; 28(1):24-27. Disponible en: https://repository.up.ac.za/bitstream/handle/2263/45264/Strauss_Excipient_2015.pdf? sequence=1

  12. Drews J. Drug discovery today and tomorrow. Drug Discov Today. 2000[citado 2 mar 2017];5(1):2-4. Disponible en: https://www.sciencedirect.com/science/article/pii/S1359644699014282?via%3Dihub

  13. Walley T. Davies Textbook of Adverse Drug Reactions. Postgrad Med J. 2000 [citado 2 mar 2017];76(901):741.Disponible en: https://pmj.bmj.com/content/76/901/741.6

  14. OMS. Vigilancia de la seguridad de los medicamentos. Suiza: OMS; 2012[citado 6 may 2017].Disponible en: http://apps.who.int/medicinedocs/documents/s21836es/s21836es.pdf

  15. Callreus T. Use of the dose, time, susceptibility (DoTS) clasification scheme for adverse drug reactions in pharmacovigilance planning. Drug Saf. 2006[citado 6 may 2017];29(7):557- 566.Disponible en: https://link.springer.com/article/10.2165/00002018-200629070-00002

  16. Schimmel EM. The hazards of hospitalization. Ann Intern Med. 1964[citado 6 may 2017]; 60: 100-110. Disponible en: http://annals.org/aim/article/679014/hazards-hospitalization

  17. Steel K, Gertman PM, Crescenzi C, Anderson J. Iatrogenic illness on a general medical service at a university hospital. N Engl J Med. 1981[citado 6 may 2017];304(11):638-642. Disponible en: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1758071/pdf/v013p00076.pdf

  18. Einarson TR. Drug-related hospital admissions. Ann Pharmacother. 1993[citado 6 may 2017];27(7-8):832-840. Disponible en: https://journals.sagepub.com/doi/pdf/10.1177/106002809302700702

  19. Muehlberger N, Schneeweiss S, Hasford J. Adverse drug reaction monitoring-cost and benefit considerations. Part I: frequency of adverse drug reactions causing hospital admissions. Pharmacoepidemiol Drug Saf. 1997[citado 6 may 2017];6(Suppl 3):71-77. Disponible en: https:// onlinelibrary.wiley.com/doi/10.1002/%28SICI%291099-1557%28199710%296%3A3%2B %3CS71%3A%3AAID-PDS282%3E3.0.CO%3B2-I

  20. Lazarou J, Pomeranz BH, Corey PN. Incidente of adverse drug reactions in hospitalizad patients: a meta-analysis of prospective studies. JAMA. 1998 [citado 12 mar 2017]; 279(15):1200-1205. Disponible en: https://jamanetwork.com/journals/jama/fullarticle/187436

  21. Roughead EE, Gilbert AL, Primrose JG, Sansom LN. Drug-related hospital admissions: a review of Australian studies published 1988-1996. Med J Aust.1998[citado 12 mar 2017]; 168(8):405-408. Disponible en: http://europepmc.org/abstract/med/9594953

  22. Alonso Hernández P, Otero López MJ, Maderuelo Fernández JA. Ingresos hospitalarios causados por medicamentos: incidencia, características y coste. Farm Hosp. 2002[citado 12 mar 2017]; 26(2): 67-134. Disponible en: http://www.elsevier.es/es-revista-farmacia-hospitalaria- 121-articulo-ingresos-hospitalarios-causados-por-medicamentos-13118908

  23. Marcum ZA, Amuan ME, Hanlon JT, Aspinall SL, Handler SM, Ruby CM, et al. Prevalence of unplanned hospitalizations caused by adverse drug reactions in older veterans. J Am Geriatr Soc. 2012[citado 12 mar 2017]; 60(1): 34-41. Disponible en: https://doi.org/10.1111/j.1532- 5415.2011.03772.x

  24. Wester K, Jönsson AK, Spigset O, Druid H, Hägg S. Incidence of faltal adverse drug reactions: a population based study. Br J Clin Pharmacol. 2007[citado 12 mar 2017]; 65(4):573-579. Disponible en: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2291376/

  25. Davies EC, Green CF, Taylor S, Williamson PR, Mottram DR, Pirmohamed M. Adverse drug reactions in hospital in-patients: a prospective analysis of 3695 patient-episodes.PLoS One. 2009[citado 12 mar 2017]; 4(2). Disponible en: http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2635959/

  26. Pirmohamed M, James S, Meakin S, Green C, Scott AK, Walley TJ, et al. Adverse drug reactions as cause of admission to hospital: Prospective analysis of 18 820 patients. BMJ. 2004[citado 23 abr 2017]; 329(7456):15-19. Disponible en: https://www.ncbi.nlm.nih.gov/pmc/ articles/PMC443443/

  27. Esteban Jiménez Ó, Navarro Pemán C, González Rubio F, Lanuza Giménez FJ, Montesa Lou C. Análisis de la incidencia y de las características clínicas de las reacciones adversas a medicamentos de uso humano en el medio hospitalario. Rev Española Sal Pú.2017 [citado 23 abr 2017]; 91.Disponible en: http://scielo.isciii.es/scielo.php?script=sci_arttext&pid=S1135- 57272017000100424&lng=es

  28. Alhawassi TM, Krass I, Bajorek BV, Pont LG. A systematic review of the prevalence and risk factors for adverse drug reactions in the elderly in the acute care setting.Clin Interv Aging. 2014 citado 2 mar 2018];9:2079-2086.Disponible en: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4257024

  29. Saedder EA, Lisby M, Nielsen LP, Bonnerup DK, Brock B. Number of drugs most frequently found to be independent risk factor for serious adverse reactions: a systematic literature review. Br J Clin Pharmacol. 2015[citado 2 mar 2018];80(4):808–817.Disponible en: https://www.ncbi.nlm.nih.gov/sites/ppmc/articles/PMC4594723/

  30. Dechanont S, Maphanta S, Butthum B, Kongkaew C. Hospital admissions/visits associated with drug drug interactions: a systematic review ‐ and meta‐analysis. Pharmacoepidemiol Drug Saf. 2014[citado 2 mar 2018];23(5):489–497.Diponible en: https://onlinelibrary.wiley.com/doi/ 10.1002/pds.3592

  31. Dumbreck S, Flynn A, Nairn M, Wilson M, Treweek S, Mercer SW, et al. Drug‐disease and drug‐drug interactions: systematic examination of recommendations in 12 UK national clinical guidelines. BMJ. 2015[citado 2 mar 2018];350. Disponible en: https://www.bmj.com/content/350/bmj.h949

  32. Kvasz M, Allen IE, Gordon MJ, Ro EY, Estok R, Olkin I, et al. Adverse drug reactions in hospitalized patients: A critique of a meta-analysis. MedGenMed. 2000[citado 2 mar 2018];2 (2). Disponible en: https://www.npcnow.org/publication/adverse-drug-reactions-hospitalizedpatients- critique-meta-analysis

  33. Camargo AL, Cardoso Ferreira MB, Heineck I. Adverse drug reactions: a cohort study in internal medicine units at a university hospital. Eur J Clin Pharmacol. 2006[citado 2 mar 2018];62(2):143-149. Disponible en: https://link.springer.com/article/10.1007/s00228-005- 0086-7

  34. Otero López MJ, Alonso Hernández P, Maderuelo Fernández JA, Ceruelo Bermejo J, Domínguez-Gil Hurlé A, Sánchez Rodríguez A. Prevalence and factors associated with preventable adverse drug events leading to hospital admission. Farm Hosp. 2006[citado 2 mar 2018];30(3):161-170. Disponible en: https://www.ncbi.nlm.nih.gov/pubmed/16999563

  35. Kongkaew C, Noyce PR, Ascroft DM. Hospital admissions associated with adverse drug reactions: a systematic review of prospective studies. Ann Pharmacother. 2008[citado 2 mar 2018];42(7-8):1017-1025. Disponible en: https://journals.sagepub.com/doi/pdf/10.1345/aph.1L037

  36. Puche Cañas E, Luna del Castillo JD. Reacciones adversas a medicamentos en pacientes que acudieron a un hospital general: un meta-análisis de resultados. An Med Interna. 2007[citado 2 mar 2018];24(12):574-578. Disponible en: http://scielo.isciii.es/scielo.php? script=sci_arttext&pid=S0212-71992007001200003&lng=es

  37. Vincent C, Neale G, Woloshynowych M. Adverse events in British hospitals: preliminary retrospective record review. BMJ. 2001[citado 2 mar 2018];322(7285):517-519. Disponible en: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC26554/

  38. Al Hamid A, Ghaleb M, Aljadhey H, Aslanpour Z. A systematic review of hospitalization resulting from medicine-related problems in adult patients. Br J Clin Pharmacol. 2014[citado 2 mar 2018];78(2):202-217. Disponible en: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4137816

  39. Prajapati K, Desai M, Shah S, Panchal J, Kapadia J, Dikshit R. An analysis of serious adverse drug reactions at a tertiary care teaching hospital. Perspect Clin Res. 2016[citado 2 mar 2018];7(4):181–186. Disponible en: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5079092/

  40. Chan S, Ang X, Sani LL, Ng HY, Whinther MD, Liu JJ, et al. Prevalence and characteristics of adverse drug reactions at admission to hospital: a prospective observational study.Br J Clin Pharmacol. 2016[citado 2 mar 2018];82(6):1636-1646.Disponible en: https://www.ncbi.nlm.nih.gov/sites/ppmc/articles/PMC5099543

  41. Peter JV, Varghese GH, Alexander H, Tom NR, Swethalekshmi V, Truman C, et al. Patterns of Adverse Drug Reaction in the Medical Wards of a Teaching Hosptal: A Prospective Observational Cohort Study. Curr Drug Saf. 2016[citado 2 mar 2018];11(2):164-171. Disponible en: http://www.eurekaselect.com/139800/article

  42. Beltrán Endo CL, Caviedes Pérez G. Reacciones adversas a medicamentos en el servicio de medicina interna del Hospital Universitario de Neiva. RFS. 2013[citado 2 mar 2018];5(2): 10-17. Disponible en: https://doi.org/10.25054/rfs.v5i2.137

  43. Martínez Rodríguez A, Duque Vizcaíno M, Castro Peraza O, Alfonso Orta I, Jiménez López G, Acosta Reynaldo ED. Notificaciones espontáneas de sospechas de reacciones adversas a los medicamentos. Instituto "Pedro Kouri". Rev Cubana Farm. 2016[citado 2 mar 2018];50(1): 53- 67. Disponible en: http://scieloprueba.sld.cu/scielo.php?script=sci_arttext&pid=S0034- 75152016000100006&lng=es

  44. Mendo Alcolea N, Cala Calviño L, Leyva Miranda T, Álvarez Escalante L, Traba Delis N. Reacciones adversas medicamentosas en pacientes con cáncer atendidos en el Hospital Oncológico Docente "Conrado Benítez". MEDISAN. 2017[citado 20 sep 2018];21(11):3145- 3151. Disponible en: http://scielo.sld.cu/scielo.php?script=sci_arttext&pid=S1029- 30192017001100002&lng=es

  45. Casas Gross SM, Gross Fernández MC, Ramos Hernández L, Herrero Aguirre H, Malo de Molina RR. Reacciones adversas a medicamentos en el Hospital Provincial Docente Clinicoquirúrgico “Saturnino Lora Torres”. MEDISAN. 2016 [citado 20 sep 2018]; 20(8). Disponible en: http://medisan.sld.cu/index.php/san/article/view/793




2020     |     www.medigraphic.com